Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma:...
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
About this item
Full title
Author / Creator
Mehra, Ranee , Seiwert, Tanguy Y. , Gupta, Shilpa , Weiss, Jared , Gluck, Iris , Eder, Joseph P. , Burtness, Barbara , Tahara, Makoto , Keam, Bhumsuk , Kang, Hyunseok , Muro, Kei , Geva, Ravit , Chung, Hyun Cheol , Lin, Chia-Chi , Aurora-Garg, Deepti , Ray, Archana , Pathiraja, Kumudu , Cheng, Jonathan , Chow, Laura Q. M. and Haddad, Robert
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Second-line treatment options for advanced head and neck squamous cell carcinoma (HNSCC) are limited. The phase Ib KEYNOTE-012 study evaluated the safety and the efficacy of pembrolizumab for the treatment of HNSCC after long-term follow-up.
Methods
Multi-centre, non-randomised trial included two HNSCC cohorts (initial and expan...
Alternative Titles
Full title
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Authors, Artists and Contributors
Author / Creator
Seiwert, Tanguy Y.
Gupta, Shilpa
Weiss, Jared
Gluck, Iris
Eder, Joseph P.
Burtness, Barbara
Tahara, Makoto
Keam, Bhumsuk
Kang, Hyunseok
Muro, Kei
Geva, Ravit
Chung, Hyun Cheol
Lin, Chia-Chi
Aurora-Garg, Deepti
Ray, Archana
Pathiraja, Kumudu
Cheng, Jonathan
Chow, Laura Q. M.
Haddad, Robert
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6048158
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6048158
Other Identifiers
ISSN
0007-0920,1532-1827
E-ISSN
1532-1827
DOI
10.1038/s41416-018-0131-9
